 | • レポートコード：MRC2312MG07204 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、77ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界のブリスターフリーシリンジワクチン市場規模と予測を収録しています。・世界のブリスターフリーシリンジワクチン市場：売上、2018年-2023年、2024年-2029年 ・世界のブリスターフリーシリンジワクチン市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界のブリスターフリーシリンジワクチン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「弱毒化生ワクチン」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 ブリスターフリーシリンジワクチンのグローバル主要企業は、Pfizer、 GSK、 Sanofi、 CSL、 Merck、 KM Biologics、 Viatris、 AstraZeneca、 Hualan Bioなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、ブリスターフリーシリンジワクチンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のブリスターフリーシリンジワクチン市場：タイプ別、2018年-2023年、2024年-2029年 世界のブリスターフリーシリンジワクチン市場：タイプ別市場シェア、2022年 ・弱毒化生ワクチン、不活化ワクチン、mRNAワクチン、DNA組換えワクチン、その他 世界のブリスターフリーシリンジワクチン市場：用途別、2018年-2023年、2024年-2029年 世界のブリスターフリーシリンジワクチン市場：用途別市場シェア、2022年 ・子供注射、大人注射 世界のブリスターフリーシリンジワクチン市場：地域・国別、2018年-2023年、2024年-2029年 世界のブリスターフリーシリンジワクチン市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるブリスターフリーシリンジワクチンのグローバル売上、2018年-2023年 ・主要企業におけるブリスターフリーシリンジワクチンのグローバル売上シェア、2022年 ・主要企業におけるブリスターフリーシリンジワクチンのグローバル販売量、2018年-2023年 ・主要企業におけるブリスターフリーシリンジワクチンのグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Pfizer、 GSK、 Sanofi、 CSL、 Merck、 KM Biologics、 Viatris、 AstraZeneca、 Hualan Bio ************************************************************* ・調査・分析レポートの概要 ブリスターフリーシリンジワクチン市場の定義 市場セグメント 世界のブリスターフリーシリンジワクチン市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のブリスターフリーシリンジワクチン市場規模 世界のブリスターフリーシリンジワクチン市場規模：2022年 VS 2029年 世界のブリスターフリーシリンジワクチン市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのブリスターフリーシリンジワクチンの売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業のブリスターフリーシリンジワクチン製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：弱毒化生ワクチン、不活化ワクチン、mRNAワクチン、DNA組換えワクチン、その他 ブリスターフリーシリンジワクチンのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：子供注射、大人注射 ブリスターフリーシリンジワクチンの用途別グローバル売上・予測 ・地域別市場分析 地域別ブリスターフリーシリンジワクチン市場規模 2022年と2029年 地域別ブリスターフリーシリンジワクチン売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Pfizer、 GSK、 Sanofi、 CSL、 Merck、 KM Biologics、 Viatris、 AstraZeneca、 Hualan Bio ... |
This research report provides a comprehensive analysis of the Blister-free Syringe Vaccine market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Blister-free Syringe Vaccine market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Blister-free Syringe Vaccine, challenges faced by the industry, and potential opportunities for market players.
The global Blister-free Syringe Vaccine market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Blister-free Syringe Vaccine market presents opportunities for various stakeholders, including Kids Injection, Adults Injection. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Blister-free Syringe Vaccine market. Additionally, the growing consumer demand present avenues for market expansion.
The global Blister-free Syringe Vaccine market was valued at US$ 4575.6 million in 2022 and is projected to reach US$ 7412.1 million by 2029, at a CAGR of 7.2% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The blister-free syringe vaccine market is driven by the pressing need for efficient and safe vaccine delivery, especially in the context of mass vaccination campaigns, as it eliminates the risks associated with handling glass vials and can improve vaccination rates. These syringes are designed to provide a reliable and convenient method for administering vaccines without the risk of glass breakage and contamination. The ease of use, reduced vaccine wastage, and potential for self-administration further contribute to market growth. However, challenges exist, including the need for rigorous quality control and assurance to ensure the reliability and safety of these syringes. Cost considerations in resource-constrained healthcare settings may also pose challenges to widespread adoption. To thrive in this market, stakeholders must address these challenges while emphasizing the benefits of blister-free syringes in enhancing vaccination efficiency and safety, particularly during public health emergencies.
Key Features:
The research report on the Blister-free Syringe Vaccine market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Blister-free Syringe Vaccine market.
Market Overview: The report provides a comprehensive overview of the Blister-free Syringe Vaccine market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Live Attenuated Vaccines, Inactivated Vaccines）, region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Blister-free Syringe Vaccine market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Blister-free Syringe Vaccine market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Blister-free Syringe Vaccine market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Blister-free Syringe Vaccine market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Blister-free Syringe Vaccine market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Blister-free Syringe Vaccine market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Blister-free Syringe Vaccine, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Blister-free Syringe Vaccine market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Blister-free Syringe Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Live Attenuated Vaccines
Inactivated Vaccines
mRNA Vaccine
DNA Recombination Vaccine
Other
Market segment by Application
Kids Injection
Adults Injection
Global Blister-free Syringe Vaccine Market Segment Percentages, By Region and Country, 2022 (%）
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Pfizer
GSK
Sanofi
CSL
Merck
KM Biologics
Viatris
AstraZeneca
Hualan Bio
Outline of Major Chapters:
Chapter 1: Introduces the definition of Blister-free Syringe Vaccine, market overview.
Chapter 2: Global Blister-free Syringe Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Blister-free Syringe Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Blister-free Syringe Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Blister-free Syringe Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Blister-free Syringe Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Blister-free Syringe Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Blister-free Syringe Vaccine Overall Market Size
2.1 Global Blister-free Syringe Vaccine Market Size: 2022 VS 2029
2.2 Global Blister-free Syringe Vaccine Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Blister-free Syringe Vaccine Sales: 2018-2029
3 Company Landscape
3.1 Top Blister-free Syringe Vaccine Players in Global Market
3.2 Top Global Blister-free Syringe Vaccine Companies Ranked by Revenue
3.3 Global Blister-free Syringe Vaccine Revenue by Companies
3.4 Global Blister-free Syringe Vaccine Sales by Companies
3.5 Global Blister-free Syringe Vaccine Price by Manufacturer (2018-2023）
3.6 Top 3 and Top 5 Blister-free Syringe Vaccine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Blister-free Syringe Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Blister-free Syringe Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Blister-free Syringe Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Blister-free Syringe Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Blister-free Syringe Vaccine Market Size Markets, 2022 & 2029
4.1.2 Live Attenuated Vaccines
4.1.3 Inactivated Vaccines
4.1.4 mRNA Vaccine
4.1.5 DNA Recombination Vaccine
4.1.6 Other
4.2 By Type – Global Blister-free Syringe Vaccine Revenue & Forecasts
4.2.1 By Type – Global Blister-free Syringe Vaccine Revenue, 2018-2023
4.2.2 By Type – Global Blister-free Syringe Vaccine Revenue, 2024-2029
4.2.3 By Type – Global Blister-free Syringe Vaccine Revenue Market Share, 2018-2029
4.3 By Type – Global Blister-free Syringe Vaccine Sales & Forecasts
4.3.1 By Type – Global Blister-free Syringe Vaccine Sales, 2018-2023
4.3.2 By Type – Global Blister-free Syringe Vaccine Sales, 2024-2029
4.3.3 By Type – Global Blister-free Syringe Vaccine Sales Market Share, 2018-2029
4.4 By Type – Global Blister-free Syringe Vaccine Price (Manufacturers Selling Prices）, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Blister-free Syringe Vaccine Market Size, 2022 & 2029
5.1.2 Kids Injection
5.1.3 Adults Injection
5.2 By Application – Global Blister-free Syringe Vaccine Revenue & Forecasts
5.2.1 By Application – Global Blister-free Syringe Vaccine Revenue, 2018-2023
5.2.2 By Application – Global Blister-free Syringe Vaccine Revenue, 2024-2029
5.2.3 By Application – Global Blister-free Syringe Vaccine Revenue Market Share, 2018-2029
5.3 By Application – Global Blister-free Syringe Vaccine Sales & Forecasts
5.3.1 By Application – Global Blister-free Syringe Vaccine Sales, 2018-2023
5.3.2 By Application – Global Blister-free Syringe Vaccine Sales, 2024-2029
5.3.3 By Application – Global Blister-free Syringe Vaccine Sales Market Share, 2018-2029
5.4 By Application – Global Blister-free Syringe Vaccine Price (Manufacturers Selling Prices）, 2018-2029
6 Sights by Region
6.1 By Region – Global Blister-free Syringe Vaccine Market Size, 2022 & 2029
6.2 By Region – Global Blister-free Syringe Vaccine Revenue & Forecasts
6.2.1 By Region – Global Blister-free Syringe Vaccine Revenue, 2018-2023
6.2.2 By Region – Global Blister-free Syringe Vaccine Revenue, 2024-2029
6.2.3 By Region – Global Blister-free Syringe Vaccine Revenue Market Share, 2018-2029
6.3 By Region – Global Blister-free Syringe Vaccine Sales & Forecasts
6.3.1 By Region – Global Blister-free Syringe Vaccine Sales, 2018-2023
6.3.2 By Region – Global Blister-free Syringe Vaccine Sales, 2024-2029
6.3.3 By Region – Global Blister-free Syringe Vaccine Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Blister-free Syringe Vaccine Revenue, 2018-2029
6.4.2 By Country – North America Blister-free Syringe Vaccine Sales, 2018-2029
6.4.3 US Blister-free Syringe Vaccine Market Size, 2018-2029
6.4.4 Canada Blister-free Syringe Vaccine Market Size, 2018-2029
6.4.5 Mexico Blister-free Syringe Vaccine Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Blister-free Syringe Vaccine Revenue, 2018-2029
6.5.2 By Country – Europe Blister-free Syringe Vaccine Sales, 2018-2029
6.5.3 Germany Blister-free Syringe Vaccine Market Size, 2018-2029
6.5.4 France Blister-free Syringe Vaccine Market Size, 2018-2029
6.5.5 U.K. Blister-free Syringe Vaccine Market Size, 2018-2029
6.5.6 Italy Blister-free Syringe Vaccine Market Size, 2018-2029
6.5.7 Russia Blister-free Syringe Vaccine Market Size, 2018-2029
6.5.8 Nordic Countries Blister-free Syringe Vaccine Market Size, 2018-2029
6.5.9 Benelux Blister-free Syringe Vaccine Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Blister-free Syringe Vaccine Revenue, 2018-2029
6.6.2 By Region – Asia Blister-free Syringe Vaccine Sales, 2018-2029
6.6.3 China Blister-free Syringe Vaccine Market Size, 2018-2029
6.6.4 Japan Blister-free Syringe Vaccine Market Size, 2018-2029
6.6.5 South Korea Blister-free Syringe Vaccine Market Size, 2018-2029
6.6.6 Southeast Asia Blister-free Syringe Vaccine Market Size, 2018-2029
6.6.7 India Blister-free Syringe Vaccine Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Blister-free Syringe Vaccine Revenue, 2018-2029
6.7.2 By Country – South America Blister-free Syringe Vaccine Sales, 2018-2029
6.7.3 Brazil Blister-free Syringe Vaccine Market Size, 2018-2029
6.7.4 Argentina Blister-free Syringe Vaccine Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Blister-free Syringe Vaccine Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Blister-free Syringe Vaccine Sales, 2018-2029
6.8.3 Turkey Blister-free Syringe Vaccine Market Size, 2018-2029
6.8.4 Israel Blister-free Syringe Vaccine Market Size, 2018-2029
6.8.5 Saudi Arabia Blister-free Syringe Vaccine Market Size, 2018-2029
6.8.6 UAE Blister-free Syringe Vaccine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Blister-free Syringe Vaccine Major Product Offerings
7.1.4 Pfizer Blister-free Syringe Vaccine Sales and Revenue in Global (2018-2023）
7.1.5 Pfizer Key News & Latest Developments
7.2 GSK
7.2.1 GSK Company Summary
7.2.2 GSK Business Overview
7.2.3 GSK Blister-free Syringe Vaccine Major Product Offerings
7.2.4 GSK Blister-free Syringe Vaccine Sales and Revenue in Global (2018-2023）
7.2.5 GSK Key News & Latest Developments
7.3 Sanofi
7.3.1 Sanofi Company Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Blister-free Syringe Vaccine Major Product Offerings
7.3.4 Sanofi Blister-free Syringe Vaccine Sales and Revenue in Global (2018-2023）
7.3.5 Sanofi Key News & Latest Developments
7.4 CSL
7.4.1 CSL Company Summary
7.4.2 CSL Business Overview
7.4.3 CSL Blister-free Syringe Vaccine Major Product Offerings
7.4.4 CSL Blister-free Syringe Vaccine Sales and Revenue in Global (2018-2023）
7.4.5 CSL Key News & Latest Developments
7.5 Merck
7.5.1 Merck Company Summary
7.5.2 Merck Business Overview
7.5.3 Merck Blister-free Syringe Vaccine Major Product Offerings
7.5.4 Merck Blister-free Syringe Vaccine Sales and Revenue in Global (2018-2023）
7.5.5 Merck Key News & Latest Developments
7.6 KM Biologics
7.6.1 KM Biologics Company Summary
7.6.2 KM Biologics Business Overview
7.6.3 KM Biologics Blister-free Syringe Vaccine Major Product Offerings
7.6.4 KM Biologics Blister-free Syringe Vaccine Sales and Revenue in Global (2018-2023）
7.6.5 KM Biologics Key News & Latest Developments
7.7 Viatris
7.7.1 Viatris Company Summary
7.7.2 Viatris Business Overview
7.7.3 Viatris Blister-free Syringe Vaccine Major Product Offerings
7.7.4 Viatris Blister-free Syringe Vaccine Sales and Revenue in Global (2018-2023）
7.7.5 Viatris Key News & Latest Developments
7.8 AstraZeneca
7.8.1 AstraZeneca Company Summary
7.8.2 AstraZeneca Business Overview
7.8.3 AstraZeneca Blister-free Syringe Vaccine Major Product Offerings
7.8.4 AstraZeneca Blister-free Syringe Vaccine Sales and Revenue in Global (2018-2023）
7.8.5 AstraZeneca Key News & Latest Developments
7.9 Hualan Bio
7.9.1 Hualan Bio Company Summary
7.9.2 Hualan Bio Business Overview
7.9.3 Hualan Bio Blister-free Syringe Vaccine Major Product Offerings
7.9.4 Hualan Bio Blister-free Syringe Vaccine Sales and Revenue in Global (2018-2023）
7.9.5 Hualan Bio Key News & Latest Developments
8 Global Blister-free Syringe Vaccine Production Capacity, Analysis
8.1 Global Blister-free Syringe Vaccine Production Capacity, 2018-2029
8.2 Blister-free Syringe Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Blister-free Syringe Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Blister-free Syringe Vaccine Supply Chain Analysis
10.1 Blister-free Syringe Vaccine Industry Value Chain
10.2 Blister-free Syringe Vaccine Upstream Market
10.3 Blister-free Syringe Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Blister-free Syringe Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer